Serum Proteomic Profiling to Identify Biomarkers of Premature Carotid Atherosclerosis

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Bhosale, Santosh D ^a   Moulder, Robert ^a   Venäläinen, Mikko S ^a   Koskinen, Juhani S ^b,f   Pitkänen, Niina ^f   Juonala, Markus T ^b   Kähönen, Mika A P ^c   Lehtimäki, Terho J ^d   Viikari, Jorma S A ^b   Elo, Laura L ^a   Goodlett, David R ^a,e   Lahesmaa, Riitta ^a   Raitakari, Olli T ^b,f  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY OF MARYLAND   (United States)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; PROTEOME;

ADULT; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY DISEASE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; FINLAND; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROTEOMICS;

ADULT; BLOOD PROTEINS; CAROTID ARTERY DISEASES; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROTEOME; PROTEOMICS; ULTRASONOGRAPHY;

EID: 85048705188     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-27265-9     Document Type: Article

References (50)

1. Kim, A. S. & Johnston, S. C. Global variation in the relative burden of stroke and ischemic heart disease. Circulation 124, 314-323 (2011).
2. Williams, K. J. & Tabas, I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15, 551-61 (1995).
3. Williams, K. J. & Tabas, I. The response-to-retention hypothesis of atherogenesis reinforced. Curr. Opin. Lipidol. 9, 471-474 (1998).
4. Libby, P. Inflammation in atherosclerosis. Nature 420, 868-74 (2002).
5. O'Leary, D. H. & Bots, M. L. Imaging of atherosclerosis: carotid intima-media thickness. Eur. Heart J. 31, 1682-1689 (2010).
6. Rundek, T. et al. The relationship between carotid intima-media thickness and carotid plaque in the Northern Manhattan Study. Atherosclerosis 241, 364-370 (2015).
7. McGill, H. C. J. et al. Origin of atherosclerosis in childhood and adolescence. in American Journal of Clinical Nutrition 72 (2000).
8. Eberini, I. et al. A proteomic portrait of atherosclerosis. J. Proteomics 82, 92-112 (2013).
9. Didangelos, A., Stegemann, C. & Mayr, M. The-omics era: Proteomics and lipidomics in vascular research. Atherosclerosis 221, 12-17 (2012).
10. Saarikoski, L. A. et al. Adiponectin is related with carotid artery intima-media thickness and brachial flow-mediated dilatation in young adults-the Cardiovascular Risk in Young Finns Study. Ann. Med. 42, 603-611 (2010).
11. Oikonen, M. et al. Tissue inhibitor of matrix metalloproteinases 4 (TIMP4) in a population of young adults: relations to cardiovascular risk markers and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study. Scand. J. Clin. Lab. Invest. 72, 540-546 (2012).
12. DeGraba, T. J. et al. Biomarker Discovery in Serum from Patients with Carotid Atherosclerosis. Cerebrovasc. Dis. Extra 1, 115-129 (2011).
13. Kristensen, L. P. et al. Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin. J. Proteomics 101, 141-153 (2014).
14. Malaud, E. et al. Local carotid atherosclerotic plaque proteins for the identification of circulating biomarkers in coronary patients. Atherosclerosis 233, 551-558 (2014).
15. Raiko, J. R. et al. Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors. J. Intern. Med. 267, 370-384 (2010).
16. Bantscheff, M., Lemeer, S., Savitski, M. M. & Kuster, B. Quantitative mass spectrometry in proteomics: Critical review update from 2007 to the present. Analytical and Bioanalytical Chemistry 404, 939-965 (2012).
17. Escher, C. et al. Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12, 1111-1121 (2012).
18. Argraves, W. S., Greene, L. M., Cooley, M. A. & Gallagher, W. M. Fibulins: physiological and disease perspectives. EMBO Rep. 4, 1127-1131 (2003).
19. Kawata, K., Tanaka, A., Arai, M., Argraves, W. S. & Fukutake, K. Alteration of plasma fibulin-1 concentrations in ischemic heart diseases. Jpn. J. Thromb. Hemost. 12, 126-132 (2001).
20. Laugesen, E. et al. Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: A cross-sectional study. Cardiovasc. Diabetol. 12 (2013).
21. Cangemi, C. et al. Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin. Chem. 57, 1556-1565 (2011).
22. Argraves, W. S. et al. Fibulin-1 and fibrinogen in human atherosclerotic lesions. Histochem. Cell Biol. 132, 559-565 (2009).
23. Paapstel, K. et al. Association Between Fibulin-1 and Aortic Augmentation Index in Male Patients with Peripheral Arterial Disease. Eur. J. Vasc. Endovasc. Surg. 51, 76-82 (2016).
24. Van Popele, N. M. et al. Association between arterial stiffness and atherosclerosis: The Rotterdam study. Stroke 32, 454-460 (2001).
25. Overgaard, M., Cangemi, C., Jensen, M. L., Argraves, W. S. & Rasmussen, L. M. Total and isoform-specific quantitative assessment of circulating fibulin-1 using selected reaction monitoring MS and time-resolved immunofluorometry. Proteomics-Clin. Appl. 9, 767-775 (2015).
26. Smith, L. M. & Kelleher, N. L. Proteoform: A single term describing protein complexity. Nature Methods 10, 186-187 (2013).
27. de la Cuesta, F. et al. Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. J. Proteomics 75, 2960-2971 (2012).
28. Rafieian-Kopaei, M., Setorki, M., Doudi, M., Baradaran, A. & Nasri, H. Atherosclerosis: Process, indicators, risk factors and new hopes. International Journal of Preventive Medicine 5, 927-946 (2014).
29. Gambardella, J., Sardu, C., Sacra, C., Del Giudice, C. & Santulli, G. Quit smoking to outsmart atherogenesis: Molecular mechanisms underlying clinical evidence. Atherosclerosis 257, 242-245 (2017).
30. Raitakari, O. T. et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290, 2277-83 (2003).
31. Tonstad, S. et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler. Thromb. Vasc. Biol. 16, 984-91 (1996).
32. Bhosale, S. D., Moulder, R., Kouvonen, P., Lahesmaa, R. & Goodlett, D. R. Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation. Methods Mol. Biol. 1619, 451-466 (2017).
33. Mallick, P. et al. Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 25, 125-131 (2007).
34. Cox, J. et al. Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment. J. Proteome Res. 10, 1794-1805 (2011).
35. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotech 26, 1367-1372 (2008).
36. Cox, J., Hein, M. Y., Luber, Ca & Paron, I. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell.. 13, 2513-2526 (2014).
37. Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods, https://doi.org/10.1038/nmeth.3901 (2016).
38. Nesvizhskii, A. I. & Aebersold, R. Interpretation of Shotgun Proteomic Data: The Protein Inference Problem. Mol Cell Proteomics 4, 1419-1440 (2005).
39. Deeb, S. J. et al. Machine Learning Based Classification of Diffuse Large B-cell Lymphoma Patients by their Protein Expression Profiles. Mol. Cell. Proteomics 2947-2960, https://doi.org/10.1074/mcp.M115.050245 (2015).
40. R Development Core Team, R. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing 1 (2011).
41. MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966-968 (2010).
42. Elo, L. L., Filén, S., Lahesmaa, R. & Aittokallio, T. Reproducibility-optimized test statistic for ranking genes in microarray studies. In IEEE/ACM Transactions on Computational Biology and Bioinformatics 5, 423-431 (2008).
43. Suomi, T., Seyednasrollah, F., Jaakkola, M. K., Faux, T. & Elo, L. L. ROTS: An R package for reproducibility-optimized statistical testing. Plos Comput. Biol. 13 (2017).
44. Tibshirani, R. Regression Selection and Shrinkage via the Lasso. Journal of the Royal Statistical Society B 58, 267-288 (1996).
45. Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J. Stat. Softw. 33 (2010).
46. DeLong, E. R., DeLong, D. M. & Clarke-Pearson, D. L. Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach. Biometrics 44, 837 (1988).
47. Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12, 77 (2011).
48. Choi, M. et al. MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics, https://doi.org/10.1093/bioinformatics/btu305 (2014).
49. Vizcaíno, J. A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44, D447-D456 (2016).
50. Farrah, T. et al. PASSEL: The PeptideAtlas SRMexperiment library. Proteomics 12, 1170-1175 (2012).